|
Volumn 68, Issue 1, 2006, Pages 52-56
|
Large clinical trials in epilepsy: Funding by the NIH versus pharmaceutical industry
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
ETIRACETAM;
LAMOTRIGINE;
PLACEBO;
TOPIRAMATE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG APPROVAL;
DRUG COMPARISON;
DRUG DEVELOPMENT;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SAFETY;
DRUG SCREENING;
DRUG TOLERABILITY;
EPILEPSY;
FUNDING;
HUMAN;
LONG TERM CARE;
MONOTHERAPY;
PRESCRIPTION;
PRIORITY JOURNAL;
SHORT COURSE THERAPY;
ANTICONVULSANTS;
DRUG EVALUATION, PRECLINICAL;
DRUG INDUSTRY;
EPILEPSY;
FINANCING, GOVERNMENT;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
RANDOMIZED CONTROLLED TRIALS;
RESEARCH SUPPORT;
UNITED STATES;
|
EID: 30144434994
PISSN: 09201211
EISSN: None
Source Type: Journal
DOI: 10.1016/j.eplepsyres.2005.09.020 Document Type: Conference Paper |
Times cited : (8)
|
References (9)
|